Maladie de Kawasaki : mise à jour [Kawasaki disease: an update]

Détails

ID Serval
serval:BIB_CC169D201112
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Titre
Maladie de Kawasaki : mise à jour [Kawasaki disease: an update]
Périodique
Revue medicale suisse
Auteur(s)
Bressieux-Degueldre S., Schaffner D., Hofer M., Sekarski N., Vanoni F.
ISSN
1660-9379 (Print)
ISSN-L
1660-9379
Statut éditorial
Publié
Date de publication
14/02/2018
Peer-reviewed
Oui
Volume
14
Numéro
594
Pages
384-389
Langue
français
Notes
Publication types: Journal Article
Publication Status: ppublish
Résumé
The cause of Kawasaki disease (KD) is still unknown, but an infectious origin and genetic susceptibility have been suggested. The American Heart Association has changed the guidelines for diagnosis and treatment of KD in 2017. One goal is to better identify patients most at risk, particularly young children with « incomplete » KD. In case of intravenous immunoglobulin resistance, alternative treatments to the traditional use of corticosteroids, such as TNF-alpha inhibitors have been proposed. For all patients with coronary aneurisms, regular assessment of myocardial perfusion is recommended, either with stress echocardiography, MRI, scintigraphy or PET-scan.
Mots-clé
Child, Humans, Immunoglobulins, Intravenous/therapeutic use, Mucocutaneous Lymph Node Syndrome/diagnosis, Mucocutaneous Lymph Node Syndrome/drug therapy, Tumor Necrosis Factor-alpha
Pubmed
Création de la notice
01/03/2018 19:49
Dernière modification de la notice
14/05/2019 6:11
Données d'usage